Hexagon Capital Partners LLC Boston Scientific Corp Transaction History

Hexagon Capital Partners LLC

$524 Million
Q1 2025

A detailed history of Hexagon Capital Partners LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 4,876 shares of BSX stock, worth $509,932. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,876

Previous 4,762 2.39%

Holding current value

$509,932

Previous $425,000 15.53%

% of portfolio

0.09%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$89.38 - $106.18 $10,189 - $12,104	114 Added 2.39%	4,876 $491,000
Q4 2024 Feb 07, 2025	BUY	$83.62 - $91.5 $10,619 - $11,620	127 Added 2.74%	4,762 $425,000
Q3 2024 Oct 08, 2024	SELL	$72.96 - $84.0 $3,575 - $4,116	-49 Reduced 1.05%	4,635 $388,000
Q2 2024 Jul 12, 2024	SELL	$67.33 - $77.71 $13,129 - $15,153	-195 Reduced 4.0%	4,684 $360,000
Q1 2024 Apr 18, 2024	SELL	$57.6 - $68.62 $8,064 - $9,606	-140 Reduced 2.79%	4,879 $334,000
Q4 2023 Feb 05, 2024	BUY	$48.64 - $57.81 $6,615 - $7,862	136 Added 2.79%	5,019 $290,000
Q3 2023 Oct 23, 2023	SELL	$50.19 - $54.68 $1,505 - $1,640	-30 Reduced 0.61%	4,883 $257,000
Q2 2023 Jul 24, 2023	SELL	$49.72 - $54.64 $9,894 - $10,873	-199 Reduced 3.89%	4,913 $265,000
Q1 2023 Apr 24, 2023	SELL	$45.09 - $50.03 $20,290 - $22,513	-450 Reduced 8.09%	5,112 $255,000
Q4 2022 Jan 13, 2023	SELL	$39.56 - $47.22 $9,969 - $11,899	-252 Reduced 4.33%	5,562 $0
Q3 2022 Oct 17, 2022	SELL	$36.71 - $109.66 $41,482 - $123,915	-1,130 Reduced 16.27%	5,814 $225,000
Q2 2022 Jul 21, 2022	SELL	$35.24 - $47.1 $8,140 - $10,880	-231 Reduced 3.22%	6,944 $259,000
Q4 2021 Jan 27, 2022	SELL	$38.07 - $44.87 $5,710 - $6,730	-150 Reduced 2.05%	7,175 $305,000
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $26,510 - $29,500	-643 Reduced 8.07%	7,325 $318,000
Q2 2021 Aug 11, 2021	SELL	$38.58 - $44.24 $259,990 - $298,133	-6,739 Reduced 45.82%	7,968 $341,000
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $129,052 - $145,152	-3,659 Reduced 19.92%	14,707 $568,000
Q4 2020 Feb 05, 2021	BUY	$33.15 - $41.97 $31,492 - $39,871	950 Added 5.45%	18,366 $660,000
Q3 2020 Nov 10, 2020	BUY	$34.44 - $42.23 $599,807 - $735,477	17,416 New	17,416 $601,000

Others Institutions Holding BSX

# of Institutions

1,833

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Account

Hexagon Capital Partners LLC Boston Scientific Corp Transaction History